Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach

Cure rates for primary mediastinal large B-cell lymphoma (PMBCL) have improved with the integration of rituximab. However, the type of primary therapy and role of radiotherapy (RT) remains ill-defined. Herein, we evaluated the outcome of PMBCL primarily treated with rituximab, cyclophosphamide, doxo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood Jg. 136; H. 24; S. 2803
Hauptverfasser:	Hayden, Anna R, Tonseth, Petter, Lee, Derrick G, Villa, Diego, Gerrie, Alina S, Scott, David W, Freeman, Ciara L, Slack, Graham W, Farinha, Pedro, Skinnider, Brian, Yenson, Paul R, Benard, Francois, Lo, Andrea, Pickles, Tom, Wilson, Donald, Connors, Joseph M, Sehn, Laurie H, Savage, Kerry J
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 10.12.2020
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - administration & dosage Cyclophosphamide - administration & dosage Disease-Free Survival Doxorubicin - administration & dosage Female Follow-Up Studies Humans Lymphoma, Large B-Cell, Diffuse - diagnostic imaging Lymphoma, Large B-Cell, Diffuse - drug therapy Lymphoma, Large B-Cell, Diffuse - mortality Male Mediastinal Neoplasms - diagnostic imaging Mediastinal Neoplasms - drug therapy Mediastinal Neoplasms - mortality Middle Aged Positron-Emission Tomography Prednisone - administration & dosage Rituximab - administration & dosage Survival Rate Vincristine - administration & dosage
ISSN:	1528-0020, 1528-0020
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!